BackgroundWomen in sub-Saharan Africa are in urgent need of female-initiated human immunodeficiency virus (HIV) preventative methods. Vaginal rings are one dosage form in development for delivery of H
RCT: random clinical trial, O: oral contraceptive use, E: estrogen replacement, P: progestin replacement, E+P: estrogen and progestin combination therapy, NG: Not Given or No limitation.
This study focusing on overactive bladder disorder (OAB) symptoms was part of a three-month randomized, doubleblinded, placebo-controlled trial (ClinicalTrials.gov NCT05013593) investigating fermented
